Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Propofol
Revenue, means the sales value of Propofol
This report studies sales (consumption) of Propofol in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
AstraZeneca
Fresenius Kabi
B.Braun Melsungen AG
Hospira
Xi’an Libang
China National Medicines Guorui
Guangdong Jiabo
Jiangsu Nhwa
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Propofol in each application, can be divided into
Application 1
Application 2
Application 3
United States Propofol Market Report 2016
1 Propofol Overview
1.1 Product Overview and Scope of Propofol
1.2 Classification of Propofol
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Propofol
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Propofol (2011-2021)
1.4.1 United States Propofol Sales and Growth Rate (2011-2021)
1.4.2 United States Propofol Revenue and Growth Rate (2011-2021)
2 United States Propofol Competition by Manufacturers
2.1 United States Propofol Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Propofol Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Propofol Average Price by Manufactures (2015 and 2016)
2.4 Propofol Market Competitive Situation and Trends
2.4.1 Propofol Market Concentration Rate
2.4.2 Propofol Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Propofol Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Propofol Sales and Market Share by Type (2011-2016)
3.2 United States Propofol Revenue and Market Share by Type (2011-2016)
3.3 United States Propofol Price by Type (2011-2016)
3.4 United States Propofol Sales Growth Rate by Type (2011-2016)
4 United States Propofol Sales (Volume) by Application (2011-2016)
4.1 United States Propofol Sales and Market Share by Application (2011-2016)
4.2 United States Propofol Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Propofol Manufacturers Profiles/Analysis
5.1 AstraZeneca
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Propofol Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 AstraZeneca Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Fresenius Kabi
5.2.2 Propofol Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Fresenius Kabi Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 B.Braun Melsungen AG
5.3.2 Propofol Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 B.Braun Melsungen AG Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Hospira
5.4.2 Propofol Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Hospira Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Xi’an Libang
5.5.2 Propofol Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Xi’an Libang Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 China National Medicines Guorui
5.6.2 Propofol Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 China National Medicines Guorui Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Guangdong Jiabo
5.7.2 Propofol Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Guangdong Jiabo Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Jiangsu Nhwa
5.8.2 Propofol Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Jiangsu Nhwa Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
6 Propofol Manufacturing Cost Analysis
6.1 Propofol Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Propofol
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Propofol Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Propofol Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Propofol Market Forecast (2016-2021)
10.1 United States Propofol Sales, Revenue Forecast (2016-2021)
10.2 United States Propofol Sales Forecast by Type (2016-2021)
10.3 United States Propofol Sales Forecast by Application (2016-2021)
10.4 Propofol Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Propofol
Table Classification of Propofol
Figure United States Sales Market Share of Propofol by Type in 2015
Table Application of Propofol
Figure United States Sales Market Share of Propofol by Application in 2015
Figure United States Propofol Sales and Growth Rate (2011-2021)
Figure United States Propofol Revenue and Growth Rate (2011-2021)
Table United States Propofol Sales of Key Manufacturers (2015 and 2016)
Table United States Propofol Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Propofol Sales Share by Manufacturers
Figure 2016 Propofol Sales Share by Manufacturers
Table United States Propofol Revenue by Manufacturers (2015 and 2016)
Table United States Propofol Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Propofol Revenue Share by Manufacturers
Table 2016 United States Propofol Revenue Share by Manufacturers
Table United States Market Propofol Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Propofol Average Price of Key Manufacturers in 2015
Figure Propofol Market Share of Top 3 Manufacturers
Figure Propofol Market Share of Top 5 Manufacturers
Table United States Propofol Sales by Type (2011-2016)
Table United States Propofol Sales Share by Type (2011-2016)
Figure United States Propofol Sales Market Share by Type in 2015
Table United States Propofol Revenue and Market Share by Type (2011-2016)
Table United States Propofol Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Propofol by Type (2011-2016)
Table United States Propofol Price by Type (2011-2016)
Figure United States Propofol Sales Growth Rate by Type (2011-2016)
Table United States Propofol Sales by Application (2011-2016)
Table United States Propofol Sales Market Share by Application (2011-2016)
Figure United States Propofol Sales Market Share by Application in 2015
Table United States Propofol Sales Growth Rate by Application (2011-2016)
Figure United States Propofol Sales Growth Rate by Application (2011-2016)
Table AstraZeneca Basic Information List
Table AstraZeneca Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Propofol Sales Market Share (2011-2016)
Table Fresenius Kabi Basic Information List
Table Fresenius Kabi Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fresenius Kabi Propofol Sales Market Share (2011-2016)
Table B.Braun Melsungen AG Basic Information List
Table B.Braun Melsungen AG Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table B.Braun Melsungen AG Propofol Sales Market Share (2011-2016)
Table Hospira Basic Information List
Table Hospira Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hospira Propofol Sales Market Share (2011-2016)
Table Xi’an Libang Basic Information List
Table Xi’an Libang Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Xi’an Libang Propofol Sales Market Share (2011-2016)
Table China National Medicines Guorui Basic Information List
Table China National Medicines Guorui Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table China National Medicines Guorui Propofol Sales Market Share (2011-2016)
Table Guangdong Jiabo Basic Information List
Table Guangdong Jiabo Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Guangdong Jiabo Propofol Sales Market Share (2011-2016)
Table Jiangsu Nhwa Basic Information List
Table Jiangsu Nhwa Propofol Sales, Revenue, Price and Gross Margin (2011-2016)
Table Jiangsu Nhwa Propofol Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Propofol
Figure Manufacturing Process Analysis of Propofol
Figure Propofol Industrial Chain Analysis
Table Raw Materials Sources of Propofol Major Manufacturers in 2015
Table Major Buyers of Propofol
Table Distributors/Traders List
Figure United States Propofol Production and Growth Rate Forecast (2016-2021)
Figure United States Propofol Revenue and Growth Rate Forecast (2016-2021)
Table United States Propofol Production Forecast by Type (2016-2021)
Table United States Propofol Consumption Forecast by Application (2016-2021)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...